Truvaga Plus review: the right pedigree, the wrong product to claim it

Truvaga is made by electroCore, a publicly traded company that also makes gammaCore. This is the most interesting fact about the product and the most misread.

gammaCore is a real cleared medical device. The FDA's own 510(k) database lists five clearances for electroCore, starting with a De Novo authorisation in 2017:

A PubMed search for gammaCore returns 127 records. A PubMed search for Truvaga returns none.

So here is the honest version. This company has demonstrably done the hard thing: taken a neck worn vagus nerve device through regulatory clearance and into published research. It has not done that for Truvaga. Every clearance above belongs to gammaCore, a prescription device for headache conditions, and clearances do not transfer between products.

Truvaga's own website describes its products as general wellness. That is the accurate category, and it is the company saying so rather than us.

What the heritage does buy you is reasonable confidence in the engineering. The waveform and the placement come from a company that has built this before. That is worth something. It is not worth mistaking for evidence.

Set the regulatory question aside and there is a real case for this device, and it is about time.

Nurosym asks for 30 to 60 minutes a day. Pulsetto runs 4 to 20 minutes depending on program. Truvaga asks for two. In a category where the most common failure is people quietly stopping after a fortnight, the shortest session is not a gimmick.

The published work in this field almost all used longer protocols, so nobody can tell you whether two minutes delivers a comparable dose. What can be said is that two minutes performed daily beats sixty minutes abandoned in week two, and only one of those is a real option for most people.

You hold it. Truvaga is handheld and stimulates one side of the neck at a time. A worn band that treats both sides while your hands are free is a materially different experience, and it costs less.

The price sits awkwardly. At $499 it is nearly twice Pulsetto and just over half Nurosym. It is not the cheap option and it is not the evidence option, which leaves the two minutes carrying the entire argument.

There is a consumable. A conductive electrode spray, which the company says lasts around two months per bottle. Not expensive, but it is a recurring item to remember.

Buy it if you have already failed to sustain a longer routine and you are honest with yourself that two minutes is the only thing you will keep doing.

Do not buy it if you are paying for research. Nothing published names this device, and the clearances you may have read about belong to gammaCore.

Consider instead: Pulsetto at $259 for hands free wear at half the price, or Nurosym at $900 if the published record is what you actually want.